Biopharmaceutical company Miragen Therapeutics went public in February after a reverse merger with Signal Genetics and taking the Carlsbad, Calif.
Growth Capitalist (https://growthcapitalist.com/2017/11/as-sendgrid-preps-for-public-debut-the-ipo-market-appears-receptive/)
Biopharmaceutical company Miragen Therapeutics went public in February after a reverse merger with Signal Genetics and taking the Carlsbad, Calif.